At the Intersection of Science and Law Titelbild

At the Intersection of Science and Law

At the Intersection of Science and Law

Von: DLA Piper
Jetzt kostenlos hören, ohne Abo

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

 In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.2026 DLA Piper Wissenschaft
Folgen
  • Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

    Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
    Nov 15 2024

    In this episode, Quest Diagnostics’ Adam Donat is joined by DLA Piper’s Kirsten Axelsen, Rachel Portman, and Jae Kim to discuss the increasing complexity and cost of clinical trials, new FDA guidance, innovative trial designs and tools, and what’s expected in the new year.

    See omnystudio.com/listener for privacy information.
    Mehr anzeigen Weniger anzeigen
    30 Min.
  • Life sciences companies and the risks posed by the mifepristone litigation

    Life sciences companies and the risks posed by the mifepristone litigation
    May 19 2023

    In this episode, a cross-disciplinary team of FDA regulatory lawyers and life sciences litigators discuss the implications of the mifepristone litigation for life sciences companies as it pertains to citizen petitions, FDA approvals, and strategies manufacturers might consider going forward.

    See omnystudio.com/listener for privacy information.
    Mehr anzeigen Weniger anzeigen
    33 Min.
  • Trade secrets protection in the life sciences sector

    Trade secrets protection in the life sciences sector
    Apr 12 2023

    DLA Piper’s Roberto Valenti and Ray Miller discuss trade secrets protection in the US and Europe and the peculiarities within the life sciences sector. Our speakers provide pragmatic approaches and suggestions on how to manage trade secrets for both pharmaceutical companies and medical device manufacturers.

    See omnystudio.com/listener for privacy information.
    Mehr anzeigen Weniger anzeigen
    21 Min.
Noch keine Rezensionen vorhanden